questionsmedicales.fr
Cellules
Neurones
Neurofibres
Neurofibres : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Neuropathie
Examen neurologique
Électromyographie
Potentiels évoqués
Imagerie par résonance magnétique
Lésions nerveuses
Conduction nerveuse
Tests de conduction
Symptômes
5
Neuropathie périphérique
Réflexes
Neurofibres
Types de neuropathie
Prévention
5
Tabagisme
Vaisseaux sanguins
Traitements
5
Traitement
Thérapie physique
Analgésiques
Anticonvulsivants
Physiothérapie
Force musculaire
Intervention chirurgicale
Symptômes graves
Efficacité
Causes de neuropathie
Complications
5
Amputation
Lésions nerveuses
Troubles de la marche
Coordination
Dépression
Douleur chronique
Réversibilité
Traitement approprié
Facteurs de risque
5
Facteurs de risque
Diabète
Antécédents familiaux
Risque individuel
Diabète
Neuropathie périphérique
Carences nutritionnelles
Vitamines B
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Neurofibres : Questions médicales les plus fréquentes",
"headline": "Neurofibres : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Neurofibres : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-06",
"dateModified": "2025-04-01",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Neurofibres"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Neurones",
"url": "https://questionsmedicales.fr/mesh/D009474",
"about": {
"@type": "MedicalCondition",
"name": "Neurones",
"code": {
"@type": "MedicalCode",
"code": "D009474",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Neurofibres adrénergiques",
"alternateName": "Adrenergic Fibers",
"url": "https://questionsmedicales.fr/mesh/D000320",
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres adrénergiques",
"code": {
"@type": "MedicalCode",
"code": "D000320",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.075"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Neurofibres autonomes postganglionnaires",
"alternateName": "Autonomic Fibers, Postganglionic",
"url": "https://questionsmedicales.fr/mesh/D001338",
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres autonomes postganglionnaires",
"code": {
"@type": "MedicalCode",
"code": "D001338",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.100"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Neurofibres sympathiques postganglionnaires",
"alternateName": "Sympathetic Fibers, Postganglionic",
"url": "https://questionsmedicales.fr/mesh/D017779",
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres sympathiques postganglionnaires",
"code": {
"@type": "MedicalCode",
"code": "D017779",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.100.800"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Axones",
"alternateName": "Axons",
"url": "https://questionsmedicales.fr/mesh/D001369",
"about": {
"@type": "MedicalCondition",
"name": "Axones",
"code": {
"@type": "MedicalCode",
"code": "D001369",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.145"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Segment initial de l'axone",
"alternateName": "Axon Initial Segment",
"url": "https://questionsmedicales.fr/mesh/D000071040",
"about": {
"@type": "MedicalCondition",
"name": "Segment initial de l'axone",
"code": {
"@type": "MedicalCode",
"code": "D000071040",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.145.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cônes de croissance",
"alternateName": "Growth Cones",
"url": "https://questionsmedicales.fr/mesh/D020439",
"about": {
"@type": "MedicalCondition",
"name": "Cônes de croissance",
"code": {
"@type": "MedicalCode",
"code": "D020439",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.145.375"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Fibres moussues de l'hippocampe",
"alternateName": "Mossy Fibers, Hippocampal",
"url": "https://questionsmedicales.fr/mesh/D019599",
"about": {
"@type": "MedicalCondition",
"name": "Fibres moussues de l'hippocampe",
"code": {
"@type": "MedicalCode",
"code": "D019599",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.145.438"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Terminaisons présynaptiques",
"alternateName": "Presynaptic Terminals",
"url": "https://questionsmedicales.fr/mesh/D017729",
"about": {
"@type": "MedicalCondition",
"name": "Terminaisons présynaptiques",
"code": {
"@type": "MedicalCode",
"code": "D017729",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.145.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Collatéraux de Schaffer",
"alternateName": "Schaffer Collaterals",
"url": "https://questionsmedicales.fr/mesh/D000094282",
"about": {
"@type": "MedicalCondition",
"name": "Collatéraux de Schaffer",
"code": {
"@type": "MedicalCode",
"code": "D000094282",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.145.875"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Neurofibres cholinergiques",
"alternateName": "Cholinergic Fibers",
"url": "https://questionsmedicales.fr/mesh/D002799",
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres cholinergiques",
"code": {
"@type": "MedicalCode",
"code": "D002799",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.234"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Neurofibres autonomes préganglionnaires",
"alternateName": "Autonomic Fibers, Preganglionic",
"url": "https://questionsmedicales.fr/mesh/D001339",
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres autonomes préganglionnaires",
"code": {
"@type": "MedicalCode",
"code": "D001339",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.234.060"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Neurofibres parasympathiques postganglionnaires",
"alternateName": "Parasympathetic Fibers, Postganglionic",
"url": "https://questionsmedicales.fr/mesh/D017777",
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres parasympathiques postganglionnaires",
"code": {
"@type": "MedicalCode",
"code": "D017777",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.234.700"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Gaine de myéline",
"alternateName": "Myelin Sheath",
"url": "https://questionsmedicales.fr/mesh/D009186",
"about": {
"@type": "MedicalCondition",
"name": "Gaine de myéline",
"code": {
"@type": "MedicalCode",
"code": "D009186",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.512.560"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Gaine de Schwann",
"alternateName": "Neurilemma",
"url": "https://questionsmedicales.fr/mesh/D009441",
"about": {
"@type": "MedicalCondition",
"name": "Gaine de Schwann",
"code": {
"@type": "MedicalCode",
"code": "D009441",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.512.560.550"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Noeuds de Ranvier",
"alternateName": "Ranvier's Nodes",
"url": "https://questionsmedicales.fr/mesh/D011901",
"about": {
"@type": "MedicalCondition",
"name": "Noeuds de Ranvier",
"code": {
"@type": "MedicalCode",
"code": "D011901",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.512.560.700"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Neurofibres non-myélinisées",
"alternateName": "Nerve Fibers, Unmyelinated",
"url": "https://questionsmedicales.fr/mesh/D036421",
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres non-myélinisées",
"code": {
"@type": "MedicalCode",
"code": "D036421",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.756"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres",
"alternateName": "Nerve Fibers",
"code": {
"@type": "MedicalCode",
"code": "D009412",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Z V Surnina",
"url": "https://questionsmedicales.fr/author/Z%20V%20Surnina",
"affiliation": {
"@type": "Organization",
"name": "Krasnov Research Institute of Eye Diseases, Moscow, Russia."
}
},
{
"@type": "Person",
"name": "S E Avetisov",
"url": "https://questionsmedicales.fr/author/S%20E%20Avetisov",
"affiliation": {
"@type": "Organization",
"name": "Krasnov Research Institute of Eye Diseases, Moscow, Russia."
}
},
{
"@type": "Person",
"name": "Yao-Chuan Chang",
"url": "https://questionsmedicales.fr/author/Yao-Chuan%20Chang",
"affiliation": {
"@type": "Organization",
"name": "Institute of Bioelectronic Medicine, Feinstein Institutes for Medical Research, Manhasset, NY, 11030, USA."
}
},
{
"@type": "Person",
"name": "Stavros Zanos",
"url": "https://questionsmedicales.fr/author/Stavros%20Zanos",
"affiliation": {
"@type": "Organization",
"name": "Institute of Bioelectronic Medicine, Feinstein Institutes for Medical Research, Manhasset, NY, 11030, USA. Electronic address: szanos@northwell.edu."
}
},
{
"@type": "Person",
"name": "Elçin Tunçkol",
"url": "https://questionsmedicales.fr/author/El%C3%A7in%20Tun%C3%A7kol",
"affiliation": {
"@type": "Organization",
"name": "Bernstein Center for Computational Neuroscience Berlin, Humboldt-Universität zu Berlin, Philippstrasse 13, Haus 6, Berlin, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Completeness of variables in Hospital-Based Cancer Registries for prostatic malignant neoplasm.",
"datePublished": "2024-07-29",
"url": "https://questionsmedicales.fr/article/39082550",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1590/0034-7167-2023-0467"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hepatic Small Vessel Neoplasm Mimics Prostate Cancer on 18 F-DCFPyl PET/CT.",
"datePublished": "2023-01-14",
"url": "https://questionsmedicales.fr/article/36728165",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/RLU.0000000000004554"
}
},
{
"@type": "ScholarlyArticle",
"name": "Granulomatous prostatitis: mimicking locally advanced prostate adenocarcinoma.",
"datePublished": "2023-10-17",
"url": "https://questionsmedicales.fr/article/37850783",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.23750/abm.v94i5.13751"
}
},
{
"@type": "ScholarlyArticle",
"name": "Clinicopathological and immunological profiles of prostate adenocarcinoma and neuroendocrine prostate cancer.",
"datePublished": "2022-12-27",
"url": "https://questionsmedicales.fr/article/36572885",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12957-022-02841-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "The influence of prostate volume on clinical parameters in prostate cancer screening.",
"datePublished": "2022-09-13",
"url": "https://questionsmedicales.fr/article/36098911",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/jcla.24700"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Cellules",
"item": "https://questionsmedicales.fr/mesh/D002477"
},
{
"@type": "ListItem",
"position": 3,
"name": "Neurones",
"item": "https://questionsmedicales.fr/mesh/D009474"
},
{
"@type": "ListItem",
"position": 4,
"name": "Neurofibres",
"item": "https://questionsmedicales.fr/mesh/D009412"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Neurofibres - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Neurofibres",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Neurofibres",
"description": "Comment diagnostiquer une neuropathie ?\nQuels tests pour évaluer les neurofibres ?\nLes IRM sont-elles utiles pour les neurofibres ?\nQuels signes indiquent une atteinte des neurofibres ?\nComment évaluer la conduction nerveuse ?",
"url": "https://questionsmedicales.fr/mesh/D009412?mesh_terms=Prostatic+Neoplasms#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Neurofibres",
"description": "Quels sont les symptômes d'une neuropathie ?\nComment se manifeste une neuropathie périphérique ?\nLes symptômes varient-ils selon le type de neurofibres ?\nPeut-on avoir des symptômes sans lésions visibles ?\nLes symptômes s'aggravent-ils avec le temps ?",
"url": "https://questionsmedicales.fr/mesh/D009412?mesh_terms=Prostatic+Neoplasms#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Neurofibres",
"description": "Comment prévenir les neuropathies ?\nL'exercice régulier aide-t-il à prévenir les neuropathies ?\nLes habitudes alimentaires influencent-elles les neurofibres ?\nFumer augmente-t-il le risque de neuropathie ?\nLe stress a-t-il un impact sur les neurofibres ?",
"url": "https://questionsmedicales.fr/mesh/D009412?mesh_terms=Prostatic+Neoplasms#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Neurofibres",
"description": "Quels traitements existent pour les neuropathies ?\nLes médicaments peuvent-ils soulager la douleur nerveuse ?\nLa physiothérapie aide-t-elle les patients ?\nQuand envisager une intervention chirurgicale ?\nLes traitements sont-ils efficaces pour tous ?",
"url": "https://questionsmedicales.fr/mesh/D009412?mesh_terms=Prostatic+Neoplasms#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Neurofibres",
"description": "Quelles complications peuvent survenir avec une neuropathie ?\nLa neuropathie peut-elle entraîner des amputations ?\nLes troubles de la marche sont-ils une complication ?\nPeut-on développer une dépression à cause de la neuropathie ?\nLes complications sont-elles réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D009412?mesh_terms=Prostatic+Neoplasms#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Neurofibres",
"description": "Quels sont les principaux facteurs de risque de neuropathie ?\nL'âge influence-t-il le risque de neuropathie ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe diabète est-il un facteur de risque majeur ?\nLes carences nutritionnelles augmentent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D009412?mesh_terms=Prostatic+Neoplasms#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une neuropathie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un examen neurologique, des tests électrophysiologiques et des analyses sanguines sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels tests pour évaluer les neurofibres ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'électromyographie (EMG) et les potentiels évoqués sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les IRM sont-elles utiles pour les neurofibres ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les IRM peuvent visualiser les lésions nerveuses et les anomalies des neurofibres."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une atteinte des neurofibres ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs, des engourdissements ou une faiblesse musculaire peuvent indiquer une atteinte."
}
},
{
"@type": "Question",
"name": "Comment évaluer la conduction nerveuse ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de conduction nerveuse mesurent la vitesse des signaux dans les neurofibres."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une neuropathie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleur, picotements, faiblesse musculaire et perte de sensation."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une neuropathie périphérique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle se manifeste par des douleurs, des engourdissements et des réflexes diminués."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de neurofibres ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes dépendent du type de neurofibres affectées (sensitives, motrices)."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans lésions visibles ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes peuvent survenir sans lésions visibles sur les examens d'imagerie."
}
},
{
"@type": "Question",
"name": "Les symptômes s'aggravent-ils avec le temps ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans certains cas, les symptômes peuvent s'aggraver progressivement sans traitement."
}
},
{
"@type": "Question",
"name": "Comment prévenir les neuropathies ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un mode de vie sain, contrôler le diabète et éviter les toxines peuvent aider."
}
},
{
"@type": "Question",
"name": "L'exercice régulier aide-t-il à prévenir les neuropathies ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier améliore la circulation sanguine et la santé nerveuse."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles les neurofibres ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée riche en vitamines B peut soutenir la santé nerveuse."
}
},
{
"@type": "Question",
"name": "Fumer augmente-t-il le risque de neuropathie ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut endommager les vaisseaux sanguins et affecter les nerfs."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur les neurofibres ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut exacerber les symptômes nerveux et affecter la santé globale."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les neuropathies ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent médicaments, thérapies physiques et interventions chirurgicales."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils soulager la douleur nerveuse ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des analgésiques et des anticonvulsivants sont souvent prescrits pour soulager la douleur."
}
},
{
"@type": "Question",
"name": "La physiothérapie aide-t-elle les patients ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la physiothérapie peut améliorer la force musculaire et la coordination."
}
},
{
"@type": "Question",
"name": "Quand envisager une intervention chirurgicale ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une chirurgie est envisagée si les symptômes sont graves et ne répondent pas aux traitements conservateurs."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils efficaces pour tous ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité des traitements varie selon la cause et la gravité de la neuropathie."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une neuropathie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections, des blessures et des problèmes d'équilibre."
}
},
{
"@type": "Question",
"name": "La neuropathie peut-elle entraîner des amputations ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des lésions nerveuses sévères peuvent augmenter le risque d'amputation, surtout chez les diabétiques."
}
},
{
"@type": "Question",
"name": "Les troubles de la marche sont-ils une complication ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la neuropathie peut affecter la coordination et entraîner des troubles de la marche."
}
},
{
"@type": "Question",
"name": "Peut-on développer une dépression à cause de la neuropathie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la douleur chronique et les limitations fonctionnelles peuvent contribuer à la dépression."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié, d'autres non."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque de neuropathie ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le diabète, l'alcoolisme, les infections et certaines maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de neuropathie ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de neuropathie augmente avec l'âge en raison de la dégradation nerveuse."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de neuropathie peuvent augmenter le risque individuel."
}
},
{
"@type": "Question",
"name": "Le diabète est-il un facteur de risque majeur ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète est l'un des principaux facteurs de risque de neuropathie périphérique."
}
},
{
"@type": "Question",
"name": "Les carences nutritionnelles augmentent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des carences en vitamines B et en acide folique peuvent augmenter le risque de neuropathie."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 01/04/2025
Contenu vérifié selon les dernières recommandations médicales
7 publications dans cette catégorie
Affiliations :
Krasnov Research Institute of Eye Diseases, Moscow, Russia.
5 publications dans cette catégorie
Affiliations :
Krasnov Research Institute of Eye Diseases, Moscow, Russia.
Sechenov First Moscow State Medical University, Moscow, Russia.
Publications dans "Neurofibres" :
2 publications dans cette catégorie
Affiliations :
Institute of Bioelectronic Medicine, Feinstein Institutes for Medical Research, Manhasset, NY, 11030, USA.
Publications dans "Neurofibres" :
2 publications dans cette catégorie
Affiliations :
Institute of Bioelectronic Medicine, Feinstein Institutes for Medical Research, Manhasset, NY, 11030, USA. Electronic address: szanos@northwell.edu.
Publications dans "Neurofibres" :
2 publications dans cette catégorie
Affiliations :
Bernstein Center for Computational Neuroscience Berlin, Humboldt-Universität zu Berlin, Philippstrasse 13, Haus 6, Berlin, Germany.
Publications dans "Neurofibres" :
2 publications dans cette catégorie
Affiliations :
Institute for Integrative Neuroanatomy, Charité - Universitätsmedizin Berlin, CCM, Philippstrasse 12, 10115, Berlin, Germany.
Publications dans "Neurofibres" :
2 publications dans cette catégorie
Affiliations :
Bernstein Center for Computational Neuroscience Berlin, Humboldt-Universität zu Berlin, Philippstrasse 13, Haus 6, Berlin, Germany. michael.brecht@bccn-berlin.de.
NeuroCure Cluster of Excellence, Humboldt-Universität zu Berlin, Berlin, Germany. michael.brecht@bccn-berlin.de.
Publications dans "Neurofibres" :
2 publications dans cette catégorie
Affiliations :
Clinical Laboratory for Bionic Extremity Reconstruction, Department of Plastic, Reconstructive and Aesthetic Surgery, Medical University of Vienna, Vienna, Austria.
Center for Biomedical Research, Medical University of Vienna, Vienna, Austria.
Publications dans "Neurofibres" :
2 publications dans cette catégorie
Affiliations :
Center for Anatomy and Cell Biology, Medical University of Vienna, Vienna, Vienna Austria.
Publications dans "Neurofibres" :
2 publications dans cette catégorie
Affiliations :
Clinical Laboratory for Bionic Extremity Reconstruction, Department of Plastic, Reconstructive and Aesthetic Surgery, Medical University of Vienna, Vienna, Austria oskar.aszmann@meduniwien.ac.at.
Department of Plastic, Reconstructive and Aesthetic Surgery, Medical University of Vienna, Vienna, Austria.
Publications dans "Neurofibres" :
2 publications dans cette catégorie
Affiliations :
Research Institute of Eye Disease, 11A Rossolimo St., Moscow, Russian Federation, 119021.
Publications dans "Neurofibres" :
2 publications dans cette catégorie
Affiliations :
Department of Ophthalmology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do Province.
Publications dans "Neurofibres" :
2 publications dans cette catégorie
Affiliations :
Harvard Ophthalmology AI Lab, Schepens Eye Research Institute of Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts.
Publications dans "Neurofibres" :
2 publications dans cette catégorie
Affiliations :
Harvard Ophthalmology AI Lab, Schepens Eye Research Institute of Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts.
Publications dans "Neurofibres" :
1 publication dans cette catégorie
Publications dans "Neurofibres" :
1 publication dans cette catégorie
Affiliations :
Indiana University School of Optometry, Bloomington, Indiana.
Publications dans "Neurofibres" :
1 publication dans cette catégorie
Affiliations :
Indiana University School of Optometry, Bloomington, Indiana.
Publications dans "Neurofibres" :
1 publication dans cette catégorie
Affiliations :
Department of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Publications dans "Neurofibres" :
1 publication dans cette catégorie
Affiliations :
Department of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Publications dans "Neurofibres" :
1 publication dans cette catégorie
Affiliations :
Department of Neurology, University of Würzburg, Josef-Schneider-Str. 11, 97080 Würzburg, Germany.
Publications dans "Neurofibres" :
to analyze the completeness of variables from Hospital-Based Cancer Registries of cases of prostate neoplasm in the Oncology Care Network of a Brazilian state between 2000 and 2020....
an ecological time series study, based on secondary data on prostate cancer Hospital-Based Cancer Registries prostate. Data incompleteness was classified as excellent (<5%), good (between 5%-10%), fai...
there were 13,519 cases of prostate cancer in the Hospital-Based Cancer Registries analyzed. The variables "family history of cancer" (p<0.001), "alcoholism" (p<0.001), "smoking" (p<0.001), "TNM stagi...
most Hospital-Based Cancer Registries variables showed excellent completeness, but important variables had high percentages of incompleteness, such as TNM and clinical staging, in addition to alcoholi...
18 F-DCFPyl is a Food and Drug Administration-approved radiotracer that targets prostate-specific membrane antigen and is used in the detection of recurrent or metastatic prostate cancer. As its use h...
We report the case of a 63-year-old male who came to the urology clinic with an increasing value of the prostate specific antigen and an asymmetrical enlargement at the digital rectal examination. The...
Biomarkers of DNA damage repair deficiency provide opportunities for personalized treatment with immunotherapy. However, there is limited research on the immune microenvironment of adeno-neuroendocrin...
A retrospective medical record review of 66 patients with prostate cancer (PCa) was performed. PCa samples from the 66 patients were analyzed using immunohistochemical staining for the detection of ch...
Twenty patients presented with adeno-NEPC, whereas 46 presented with adeno-PCa. The median age of patients at PCa diagnosis was 67.86 ± 7.05 years (68.65 ± 7.23 years, adeno-NEPC; 67.52 ± 7.02 years, ...
Our study revealed clinicopathological manifestations of adeno-NEPC and some possible predictive factors significantly associated with better outcomes in patients with adeno-NEPC. These findings might...
The purpose of the study was to evaluate the diagnostic significance of two new and a few clinical markers for prostate cancer (PCa) at various prostate volumes (PV)....
The study subjects were divided into two groups. Among them, there were 70 cases in the PV ≤30 ml group (benign prostatic hyperplasia [BPH]: 32 cases, PCa: 38 cases) and 372 cases in the PV > 30 ml gr...
In the PV ≤30 ml group, the diagnostic parameters based on prostate-specific antigen (PSA) had a decreased diagnostic significance for PCa. In the PV > 30 ml group, PSAD (AUC = 0.709), AVR (AVR = Age/...
Choosing appropriate indicators for different PVs could contribute to the early screening and diagnosis of PCa. The difference in the diagnostic value of two new indicators (A-PSAD and AVR), and PSAD ...
The optimal treatment of metastatic castration-resistant prostate cancer (mCRPC) continues to be challenging, given the multitude of life prolonging treatment options. Radionuclide therapy delivers co...
This study aims to compare the ability of the PHI versus tPSA test to predict the presence of PCa in our population....
A prospective observational study was performed. We included patients with tPSA ≥ 2.5 ng/ml, biopsy naïve or previous negative biopsy, undergoing a blood test, which includes tPSA, fPSA, and p2PSA, an...
140 men were included. Fifty-seven (40.7%) had a positive prostate biopsy result (Group A), and 83 (59.3%) had a negative biopsy result (Group B). The mean age was similar in both groups (mean ± stand...
The PHI test improves PCa detection compared to tPSA in our population....
Holmium laser enucleation of the prostate (HoLEP) is a size-independent surgical option for treating benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) with excellent, durable ...
Noninvasive methods for the early identify diagnosis of prostatitis, benign prostatic hyperplasia (BPH), and prostate cancer (PCa) are current clinical challenges....
The serum metabolites of 20 healthy individuals and patients with prostatitis, BPH, or PCa were identified using untargeted liquid chromatography-mass spectrometry (LC-MS). In addition, targeted LC-MS...
Organic acid metabolites had good sensitivity and specificity in differentiating prostatitis, BPH, and PCa. Three diagnostic models identified patients with PROSTATITIS: phenyllactic acid (area under ...
We compare Prostate Health Index, Prostate Health Index density, and PSA density in predicting clinically significant prostate cancer in MRI-guided prostate biopsy....
This is a multicenter evaluation of prospectively maintained prostate biopsy databases at 10 urology centers. Men with Prostate Health Index and MRI-guided targeted and systematic prostate biopsy perf...
A total of 1,215 men were analyzed. Prostate cancer and clinically significant prostate cancer were diagnosed in 51% (617/1,215) and 35% (422/1,215) of men, respectively. Clinically significant prosta...
Prostate Health Index density outperformed Prostate Health Index or PSA density in clinically significant prostate cancer detection in men with multiparametric MRI performed, and further reduced unnec...